Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion type Assertion NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_head.
- NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion description "[First, we analyzed HSP70-2 polymorphism in risk-associated haplotypes from HLA homozygous cells and normal individuals and confirmed that the HSP70-2 9-kb variant was associated invariably with DR4 (HLA-DRB1*0402, DQB1*0302) and DR2 (HLA-DRB1*01601, DQB1*0502, DQA1*0102 and HLA-DRB1*1501, DQB1*0602) haplotypes, which were the haplotypes found increased in Jewish and non-Jewish patients with CA, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_provenance.
- NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion evidence source_evidence_literature NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_provenance.
- NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion SIO_000772 7579351 NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_provenance.
- NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion wasDerivedFrom befree-20140225 NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_provenance.
- NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_assertion wasGeneratedBy ECO_0000203 NP316687.RAYmlw_o1jGVvJh9FYTFWEbGfHsEvVd72PAIxq15C6KV8130_provenance.